Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Sigrid Therapeutics AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 149 Less Arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -3,753 More Arrow -2,758 More Arrow -1,966
EBITDA -3,797 More Arrow -2,788 More Arrow -1,934
Total assets 3,083 More Arrow 6,618 Less Arrow 4,943
Current assets 2,110 More Arrow 6,017 Less Arrow 4,652
Current liabilities 1,212 Less Arrow 873 Less Arrow 412
Equity capital 1,870 More Arrow 5,745 Less Arrow 4,531
- share capital 64 More Arrow 65 Less Arrow 59
Employees (average) 7 Equal arrow 7 More Arrow 9

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 60.7% More Arrow 86.8% More Arrow 91.7%
Turnover per employee 21 Less Arrow 0 Equal arrow 0
Profit as a percentage of turnover -2518.8%
Return on assets (ROA) -121.7% More Arrow -41.7% More Arrow -39.8%
Current ratio 174.1% More Arrow 689.2% More Arrow 1129.1%
Return on equity (ROE) -200.7% More Arrow -48.0% More Arrow -43.4%
Change turnover 149 Less Arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Less Arrow -2 More Arrow 2
Chg. No. of employees % 0% Less Arrow -22% More Arrow 29%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.